Navigation Links
Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
Date:3/14/2008

NEW HAVEN, Conn., March 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VIOND) today announced that it would hold a conference call on Tuesday, March 18, 2008 to discuss its 2007 fourth quarter and year-end financial results. The call will begin at 8:30 a.m. Eastern Time.

To participate in the conference call, please dial (800) 510-0146 in the U.S. (617) 614-3449 for international callers) at least 15 minutes before the start of the call. When prompted for a pass code, please enter 81583398.

An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to assure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user.

A replay of the call will be available two hours after the completion of the call at (888) 286-8010 in the U.S., (617) 801-6888 for international callers), pass code 95705866. The replay will be available through Tuesday, April 1, 2008.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a pivotal Phase II trial as a single agent in elderly patients with de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung ca
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...y on creativity, sponsored by the Jerusalem-based ...eker, revealed that a majority of the Israeli scie...al methods that could "put them into a creati...s desired." , Jerusa...ey on creativity, sponsored by the Jerusalem-based...
(Date:7/24/2008)...-FirstCall/ -- NuVasive, Inc.,(Nasdaq: NUVA ), a ...cts for,minimally disruptive surgical treatments f...d the previously announced acquisition of the Oste...Inc. (Nasdaq: OSIR ) for $35,million in cash, plu...ot to,exceed $50 million in either cash or stock, ...
(Date:7/24/2008)...nary and critical care clinicians, and resear... DURHAM, N.C., July 24 /- bioMerieux...nferences of the American Thoracic Society and,Soc...sts, pulmonary and,critical care physicians, and r...thods and technologies are needed to quickly diagn...
(Date:7/24/2008)...e/ -- Instrumentation Laboratory,(IL) today announ...ervices,company, has awarded the Company with a fi...ts and services. Broadlane, based in Dallas, TX, c...ospitals, more than 2,600,sub-acute care facilitie...contract covers IL,s portfolio of critical care an...
Breaking Biology Technology:Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3NuVasive Completes Acquisition of Osteocel Biologics Business 2NuVasive Completes Acquisition of Osteocel Biologics Business 3NuVasive Completes Acquisition of Osteocel Biologics Business 4NuVasive Completes Acquisition of Osteocel Biologics Business 5U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 2U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 3Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane 2
...s more innovation -- but how to best produce it? S...ight environment to enable inspiration and inventi...iduals to create in their own unique ways. But few...oach to creativity. Surely, many managers ask, the...uted in a consistent and repeatable manner? They b...
...Where Progress Way meets Technology Drive, "old" m...n, they decide that they really need each other. ,...n a new, 400-page analysis of the state,s manufact...xtension Manufacturing Partnership (WMEP) and pro...MPI) of Shaker Heights, Ohio. , ,The report inclu...
...rd Wave Technologies Inc. has filed suit against ...ht to sell two products, the company announced on ...Madison. , ,The company last Friday filed suit aga...ting Third Wave,s right to sell its human papillom...filed suit against Chiron Corp. , Bayer Corp., ...
...rlin, Germany plans to acquire Roentec AG, an X-...ual revenues of $6-7 million, based in Berlin. Ter...acquisition is expected to close in the fourth qua...adquarters in Madison, Wis. The worldwide X-ray mi... $150 million per year, and Bruker AXS so far has ...
Other Biology Technology:Process or practice - Choosing a path to innovation 2Process or practice - Choosing a path to innovation 3Process or practice - Choosing a path to innovation 4Whither Wisconsin manufacturing in the new global economy? 2Whither Wisconsin manufacturing in the new global economy? 3Third Wave files patent suits against Digene, Chiron and Bayer 2
(Date:7/24/2008)...m Columbia University,s Mailman School of Public H... in infant health and preventing mother-to-child H...ngs, HIV-infected mothers had been advised that fo...exclusively breast-feed, followed by a rapid weani...o the study conducted in Lusaka, Zambia by Mailman...
(Date:7/24/2008)...found a molecular link between circadian rhythms ...reveals new possibilities for the treatment of dia...lo Sassone-Corsi, Distinguished Professor and Chai...ied that an essential protein called CLOCK that re...ance with another protein called SIRT1 that modula...
(Date:7/24/2008)...ntly burning through a study area where projection... Managers used data and analysis from the Gotchen ...ing, analysis, and implementation of treatments ne...he Gotchen LSR, lies on the east slope of the Casc...cres of the Mount Adams Ranger District on the Gif...
(Date:7/23/2008)...llectively spend about $1 billion annually could p...ic tons of carbon dioxide per year for the next 25...about that much money to put an end to a tenth of ...e top contributors to greenhouse gas emissions, re...rogram could have potential to reduce global carbo...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Breakthrough in pre eclampsia test 11643 1Breakthrough in pre eclampsia test 11643 2New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 1New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 2New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 3New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 4New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 5New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 6Men who are continually active at work may have a decreased risk of prostate cancer 11636 1Men who are continually active at work may have a decreased risk of prostate cancer 11636 2Men who are continually active at work may have a decreased risk of prostate cancer 11636 3Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 1Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 2Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 3
... are critical to understanding the course of human...ars ago near the town of Hofmeyr, in the Eastern C...A study by an international team of scientists led...logy and Anatomical Sciences at Stony Brook Univer...ne has dated the skull to 36,000 years ago. This s...
...heights, they,re voracious, and Dr. Spencer Behmer...oak trees or on your house. , They,re post oak gr...iment Station entomologist, wants to research thei...ard of them, don,t feel alone. Until recently, mos...first 25 years of my career," said Dr. John Jackma...
... variations ensure that no two people are exactly .... Now, researchers have the tools and the knowled... cancer therapies, enabling them to create more ef...ized medicine. At the 2007 Annual Meeting of the A...rs present new biomarkers ?and techniques for dete...
...se with essential information to negotiate a burro...s presence. These stiff hairs relay sensory input ... first, studies of this system by Carnegie Mellon ...mpensate when limited to sensing the world through...Neuroscience, the results should help shape future...
Other Biology News:Hofmeyr skull supports the 'Out of Africa' theory 2Hofmeyr skull supports the 'Out of Africa' theory 3Post oak grasshoppers emerging 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6Carnegie Mellon University research shows how sensory-deprived brain compensates 2
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)
Detects caspase activation by flow cytometry.
Concentration: 1mg/ml. Antigen: Propidium Iodide
Apoptosis Detection Systems and Reagents
Biology Products: